NCT07623798
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- ZhongShan Hospital FuDan University Shanghai, Shanghai Municipality, China
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
Not Yet Recruiting
Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma
NCT07601100
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Not Yet Recruiting
A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement
NCT07615270
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Stanford University Palo Alto, California, United States
Not Yet Recruiting
Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma
NCT07611149
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Not Yet Recruiting
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
NCT07609940
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cytokine Release Syndrome, +19 more
- Locations
-
Not specified
Not Yet Recruiting
A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment
NCT07609706
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
NCT05976555
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
NCT07285239
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
NCT06948084
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Not Yet Recruiting
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
NCT07569757
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Beijing Chao-Yang Hospital,Capital Medical University Beijing, Beijing Municipality, China
- Beijing Jishuitan Hospital,Capital Medical University Beijing, Beijing Municipality, China